We have previously shown that FOXB2 controls Wnt pathway activity in prostate cancer cells via WNT7/RECK (29), suggesting that these and potentially other FOX family members are functionally redundant in the context of Wnt/β-catenin signaling. This evidence concerns the gene FOXB2 and prostate carcinoma.